Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
The decided trend in recent years has been toward a partial kidney resection (removal of tumor only) in cases of small kidney cancers. But contrary to past studies, new URMC data shows that people who received a partial nephrectomy did not have improved survival, according to research published this month in European Urology.
7/25/2013 | 0 comments
For the 14,400 head and neck cancer patients in the U.S., dry mouth is an unwelcome side effect of radiation therapy, causing difficulty with eating and speaking, and oral infections, among other things. Fortunately, researchers are exploring new ways to protect salivary glands during radiation treatment.
7/24/2013 | 4 comments
A new medical imaging technology – dubbed multispectral photoacoustic imaging – has demonstrated that it can successfully identify healthy vs. cancerous prostate tissue and could represent a less invasive and more accurate way to screen for the disease.
7/18/2013 | 0 comments
When the Rochester Melanoma Action Group was looking for a place to invest its first $25,000 seed grant, it found Glynis Scott, M.D., an accomplished skin pathologist at the University of Rochester Medical Center and Wilmot Cancer Center, who’s been investigating the basic biology of melanoma for several years.
6/13/2013 | 0 comments
Scientists believe they’ve figured out a way to suppress the growth of tumors by keeping DNA tightly packaged -- essentially burying some of the genes responsible for cancer. It’s a little like keeping the lid on the jack-in-the-box, said Willis Li, Ph.D., a professor of Medicine at UC San Diego, who did the work while in the Department of Biomedical Genetics at URMC.
6/6/2013 | 0 comments